Day: June 7, 2022

CEO Dr. Sean Ianchulev will transition to non-executive Chairman of the Board NEW YORK, June 07, 2022 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic pharmaceutical technology company developing a pipeline of late-stage microdose array print (MAP™) therapeutics, today announced that Dr. Sean Ianchulev, co-founder, chief medical officer and chief executive officer, will step down as chief executive officer and transition to the role of non-executive Chairman of the Board. The definitive timeline for the transition will be determined over the next few weeks. The Company and its Board have retained an executive search firm to assist in identifying the Company’s next chief executive officer. Dr. Ianchulev will continue as a consulting medical director for Eyenovia after the transition in order to support the ongoing...

The joint venture will allow for a centrally located, vertically integrated supply chain for active battery anode material supplied by two high-quality, scalable graphite operations in two strategic and stable jurisdictions in the Americas VANCOUVER, British Columbia, June 07, 2022 (GLOBE NEWSWIRE) — South Star Battery Metals Corp. (“South Star” or the “Company”) (TSXV: STS) (OTCQB: STSBF), is pleased to announce the signing of a Letter of Intent (“LOI”) with Graphex Technologies, LLC (“Graphex”) to jointly develop a manufacturing and processing facility for battery anode material. The parties intend to develop a definitive agreement by October 31, 2022 to share expertise and technology for the design, construction and operations of a battery anode material processing facility. Graphite feed stock is expected to be provided by...

Accreditation validates company has implemented the internationally recognized highest standard for managing the security of its data assets LONG BEACH, NY , June 07, 2022 (GLOBE NEWSWIRE) — authID.ai [Nasdaq: AUID], a leading provider of secure, mobile, biometric identity authentication solutions, today announced the company is an ISO 27001:2013 certified provider whose Information Security Management System (ISMS) has received third-party accreditation from the International Standards Organization (ISO). Obtaining this internationally recognized credential reaffirms authID’s commitment to providing its customers with the highest level of assurance that its systems operate within a secure environment. Issued by A-LIGN, an independent and accredited third-party auditor, the ISO 27001 certification is evidence that authID has met...

Non-refundable funds from the Next Generation-EU program MADRID, Spain and CAMBRIDGE, Mass., June 07, 2022 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that it has been awarded the Seal of Excellence, a quality label awarded by the European Commission, and a non-refundable public grant of 1.87 M €. The funding is for Oryzon’s project entitled “Development of new treatments against Acute Myeloid Leukemia (AML) using iadademstat, an epigenetic drug” with a duration of 30 months (January 2022 – June 2024). The overall goal of this project is to supplement the execution costs of iadademstat’s ongoing FRIDA clinical study, and to develop the formulation and...

Element Biosciences to provide proof-of-concept findings during panel discussion at the Advances in Genome Biology and Technology (AGBT) general meeting Olink continues its pioneering efforts to enable Explore broadly across genomics ecosystems and to democratize next-generation proteomics UPPSALA, Sweden, and SAN DIEGO, CA, June 07, 2022 (GLOBE NEWSWIRE) — Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) and Element Biosciences, Inc. (“Element”) today announced a collaboration to enable use of the Olink® Explore high-throughput proteomics platform with Element’s next generation sequencing (NGS) platform, the AVITI System, launched March 2022. Element and Olink have performed a technical proof-of-concept study demonstrating a high compatibility between Olink® Explore and Element’s NGS platform AVITI. Additional findings from the...

HighlightsInitial mineralogy completed on select samples from drill holes CF21-001 and 002 (CV5 Pegmatite), 004 (CV6 Pegmatite), and 014 (CV12 Pegmatite), indicate:Spodumene is the dominant lithium-bearing mineral present – of the samples probed grading >0.4% Li2O, spodumene accounts for 86-99% of the lithium deportment No significant petalite, lithium-phosphate minerals, or apatite present Columbite/tantalite are the dominant tantalum-bearing minerals presentPreliminary Metallurgical program initiated at SGS Canada (Lakefield) supported by 225 kg of sample drill core from holes CF21-001 and 002 at the CV5 PegmatitePrimary objective is to develop preliminary flowsheet to produce spodumene concentrate – grading >6% Li2O – at high recovery Focused on head sample characterization and mineralogy, grindability, heavy liquid separation...

Oral and moderated poster presentations of FREEDOM-HF study to be presented BURLINGTON, Mass., June 07, 2022 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that the Company has had two abstracts accepted for presentation at the American Association of Heart Failure Nurses (AAHFN) 18th Annual Meeting, which is being held June 15-18 in Orlando, Florida. “We are very pleased to present the primary results from the FREEDOM-HF study as an encore oral presentation at this year’s AAHFN annual meeting. As first reported in July 2021, heart failure patients presenting to the emergency department with worsening congestion...

RESEARCH TRIANGLE PARK, N.C., June 07, 2022 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the company will be participating in the following virtual investor conferences.Lytham Partners Summer 2022 Investor ConferenceTuesday, June 21, 2022 to Wednesday, June 22, 2022Presentation available beginning on June 21, 2022, at 9:00 a.m. Eastern TimeCowen 7th Annual FutureHealth ConferencePanel discussion titled, “Access and Affordability in Clinical Trials,” on Thursday, June 23, 2022, at 3:25 p.m. Eastern TimeInterested parties may access the webcasts of these sessions on the “Investor Relations” section of the company’s website at: https://investors.science37.com. About Science 37Science 37 Holdings, Inc.’s (Nasdaq: SNCE) mission is to enable universal...

AdobeStock_436255963 Biopolishing for MMCF is not just a quality win in terms of pilling performance. It also delivers excellent drapability as well as a soft hand feel.GettyImages-899207120 More consumers are conscious about how clothes are made and how they impact the environment.Non-polished vs biopolished fabric Top image: Not biopolished. Bottom image: Biopolished.Consumer and regulatory demands for more sustainable clothing and textiles are growing and the fashion industry is rising to the challenge. Now Novozymes offers biopolishing for manmade cellulosic fibers (MMCF) including viscose, modal and lyocell. This helps enhance the quality of fabrics, making them look new for longer and extending their lifespan. COPENHAGEN, DENMARK – June 7, 2022 – MMCF is the third most used textile fiber in the world after polyester and...